Outcome of therapy in biopsy proven lupus nephritis with cyclophosphamide or mycophenolate: Registry data from a South Indian tertiary care center

Outcome of therapy in biopsy proven lupus nephritis with cyclophosphamide or mycophenolate: Registry data from a South Indian tertiary care center

Background: Cyclophosphamide and mycophenolate are the currently proposed first-line agents for induction in lupus nephritis (LN). In this study, we analysed the response rates with the three different induction regimens currently available for LN. Methods: Patients with biopsy-proven LN with data a...

Full description

Bibliographic Details
Main Authors: Keerthi Talari, Rajendra Varaprasad Irlapati, Megha Uppin, Liza Rajasekhar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Indian Journal of Rheumatology
Subjects:
Cyclophosphamide
lupus
mycophenolate
nephritis
systemic lupus erythematosus
Online Access:http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=2;spage=76;epage=80;aulast=Talari

Internet

http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=2;spage=76;epage=80;aulast=Talari

Similar Items